实用性随机对照试验显示标准化降钙素原监测缩短社区获得性脓毒症患者抗生素疗程
Standardised procalcitonin monitoring and antibiotic duration in community-acquired sepsis: a pragmatic randomised controlled trial
在泰国一家三级医院急诊开展的实用性随机对照试验中,按第0、2、5天标准化检测降钙素原使社区获得性脓毒症患者抗生素疗程中位数由9天缩短至7天(P=0.028)。182例随机分组,排除随机后退出者后130例纳入分析(降钙素原组62例、对照组68例),平均差−1.34天(95%CI −2.60至−0.08)。
- Article
- Open access
- Published: 14 October 2026
Scientific Reports (2026) Cite this article
We’re sharing this article early to provide faster access to peer-reviewed, accepted research. It is citable and carries a permanent DOI. This version is subject to further edits and will be replaced automatically by the final Version of Record. All legal disclaimers apply.
Abstract
Prolonged antibiotic therapy drives antimicrobial resistance, yet most evidence for procalcitonin (PCT)-guided stewardship in sepsis comes from protocol-driven trials in intensive care. We conducted a pragmatic, open-label, randomised controlled trial at a tertiary emergency department in Bangkok, Thailand (February 2025–March 2026). Adults with community-acquired sepsis (infection plus two or more systemic inflammatory response syndrome criteria) were randomised 1:1 to scheduled PCT measurement on days 0, 2 and 5, with results returned through routine channels, or to standard care; treating physicians retained full discretion. The primary outcome was total antibiotic duration. Of 182 randomised participants, 130 were analysed after post-randomisation withdrawals (PCT n = 62, control n = 68). Antibiotic duration was shorter with PCT monitoring (median 7 days, interquartile range 6–10, versus 9 days, 7–12.5; Mann–Whitney exact P = 0.028; mean difference − 1.34 days, 95% confidence interval − 2.60 to − 0.08). Twenty-eight-day mortality was 4/62 (6.5%) versus 3/68 (4.4%) (risk ratio 1.46, 95% confidence interval 0.34 to 6.28) and, among all randomised participants with known status, 12/87 (13.8%) versus 16/92 (17.4%) (risk ratio 0.79, 0.40 to 1.58); the trial was not powered for mortality and cannot exclude harm. Guidance-only PCT monitoring shortened antibiotic duration in emergency department sepsis; its safety requires confirmation in a larger trial.
Trial registration: Thai Clinical Trial Registry no. TCTR20250216013 (https://www.thaiclinicaltrials.org)
Acknowledgements
The authors thank the nursing staff and emergency physicians of Bhumibol Adulyadej Hospital for their support in participant recruitment and data collection. Procalcitonin test reagents were provided at no cost by Roche Diagnostics (Thailand) as an in-kind contribution of consumables only. No monetary funding was received for this study. The company had no role in study design, data collection, analysis, interpretation, or preparation of the manuscript.
Funding
This study received no external funding. Procalcitonin test reagents were provided at no cost by Roche Diagnostics (Thailand) as an in-kind contribution of consumables only; the company had no role in the design or conduct of the study, in the collection, analysis, or interpretation of the data, or in the preparation of the manuscript.
Author information
Authors and Affiliations
Department of Medicine, Bhumibol Adulyadej Hospital, Royal Thai Air Force, Sai Mai, Bangkok, 10220, Thailand
Thien Meensuk & Natthakit Chavapradit
Authors
- Thien Meensuk
- Natthakit Chavapradit
Corresponding author
Correspondence to Natthakit Chavapradit.
Ethics declarations
Competing interests
The authors declare no competing interests.
Ethics approval and consent to participate
The trial was approved by the Institutional Review Board of Bhumibol Adulyadej Hospital, Royal Thai Air Force (approval no. 97/67, granted 31 October 2024), and was conducted in accordance with the Declaration of Helsinki. Written informed consent was obtained from all participants or their legally authorised representatives before enrolment.
Reporting standards
The trial is reported in accordance with the CONSORT 2010 guidelines. The completed checklist and the full trial protocol are provided as Supplementary Information.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
About this article
Cite this article
Meensuk, T., Chavapradit, N. Standardised procalcitonin monitoring and antibiotic duration in community-acquired sepsis: a pragmatic randomised controlled trial. Sci Rep (2026). https://doi.org/10.1038/s41598-026-75728-1
Received: 18 July 2026
Accepted: 08 October 2026
Published: 14 October 2026
DOI: https://doi.org/10.1038/s41598-026-75728-1
来源:Nature 健康护理主题 · nature.com